MarketCapTrends
VIR
Vir Biotechnology Inc. (VIR)
NASDAQ · Healthcare

Vir Biotechnology Inc. Total Liabilities 2017–2025

Vir Biotechnology Inc. annual/quarterly total liabilities history from 2018 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Vir Biotechnology Inc. total liabilities for the quarter ending December 31, 2025 were 237.5M, a 4.38% decrease year-over-year.
  • Vir Biotechnology Inc. total liabilities for 2025 were 237.5M, a 4.38% decrease from 2024.
  • Vir Biotechnology Inc. total liabilities for 2024 were 248.4M, a 24.45% decrease from 2023.
  • Vir Biotechnology Inc. total liabilities for 2023 were 328.8M, a 54.59% decrease from 2022.
  • Vir Biotechnology Inc. total liabilities for 2022 were 724.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Vir Biotechnology Inc. Annual Total Liabilities (Millions of US $)
2025$238
2024$248
2023$329
2022$724
2021$522
2020$202
2019$88
2018$62
Vir Biotechnology Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$238
2024-12-31$248
2023-12-31$329
2022-12-31$724
2021-12-31$522
2020-12-31$202
2019-12-31$88
2018-12-31$62

Vir Biotechnology Inc. Total Liabilities — FAQ

Vir Biotechnology Inc. (VIR) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see VIR's total liabilities history?

The chart and table above show Vir Biotechnology Inc.'s total liabilities by year and by quarter, including the growth rate.